These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1280266)
1. The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. Carnemolla B; Leprini A; Allemanni G; Saginati M; Zardi L J Biol Chem; 1992 Dec; 267(34):24689-92. PubMed ID: 1280266 [TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8. Ventura E; Sassi F; Parodi A; Balza E; Borsi L; Castellani P; Carnemolla B; Zardi L PLoS One; 2010 Feb; 5(2):e9145. PubMed ID: 20161770 [TBL] [Abstract][Full Text] [Related]
3. C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8. Ventura E; Cordazzo C; Quarto R; Zardi L; Rosano C PLoS One; 2016; 11(2):e0148103. PubMed ID: 26867013 [TBL] [Abstract][Full Text] [Related]
4. Localization of the cellular-fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E. coli. Carnemolla B; Borsi L; Zardi L; Owens RJ; Baralle FE FEBS Lett; 1987 May; 215(2):269-73. PubMed ID: 2438158 [TBL] [Abstract][Full Text] [Related]
5. NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis. Fattorusso R; Pellecchia M; Viti F; Neri P; Neri D; Wüthrich K Structure; 1999 Apr; 7(4):381-90. PubMed ID: 10196121 [TBL] [Abstract][Full Text] [Related]
6. Procedure for the purification of the fibronectin proteolytic fragments containing the ED-B oncofetal domain. Borsi L; Balza E; Leprini A; Ponassi M; Zardi L Anal Biochem; 1991 Feb; 192(2):372-9. PubMed ID: 2035837 [TBL] [Abstract][Full Text] [Related]
7. Identification of two amino acids within the EIIIA (ED-A) segment of fibronectin constituting the epitope for two function-blocking monoclonal antibodies. Liao YF; Wieder KG; Classen JM; Van De Water L J Biol Chem; 1999 Jun; 274(25):17876-84. PubMed ID: 10364233 [TBL] [Abstract][Full Text] [Related]
8. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Castellani P; Viale G; Dorcaratto A; Nicolo G; Kaczmarek J; Querze G; Zardi L Int J Cancer; 1994 Dec; 59(5):612-8. PubMed ID: 7525495 [TBL] [Abstract][Full Text] [Related]
9. Conformational transitions in the cell binding domain of fibronectin. Ugarova TP; Zamarron C; Veklich Y; Bowditch RD; Ginsberg MH; Weisel JW; Plow EF Biochemistry; 1995 Apr; 34(13):4457-66. PubMed ID: 7535564 [TBL] [Abstract][Full Text] [Related]
10. Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies. Siri A; Carnemolla B; Saginati M; Leprini A; Casari G; Baralle F; Zardi L Nucleic Acids Res; 1991 Feb; 19(3):525-31. PubMed ID: 1707164 [TBL] [Abstract][Full Text] [Related]
11. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. Carnemolla B; Balza E; Siri A; Zardi L; Nicotra MR; Bigotti A; Natali PG J Cell Biol; 1989 Mar; 108(3):1139-48. PubMed ID: 2646306 [TBL] [Abstract][Full Text] [Related]
12. Molecular and immunologic differences in canine fibronectins from articular cartilage and plasma. Burton-Wurster N; Lust G Arch Biochem Biophys; 1989 Feb; 269(1):32-45. PubMed ID: 2916846 [TBL] [Abstract][Full Text] [Related]
13. A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis-associated extra type III domain B. Balza E; Sassi F; Ventura E; Parodi A; Fossati S; Blalock W; Carnemolla B; Castellani P; Zardi L; Borsi L Int J Cancer; 2009 Aug; 125(4):751-8. PubMed ID: 19479996 [TBL] [Abstract][Full Text] [Related]
14. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Kaczmarek J; Castellani P; Nicolo G; Spina B; Allemanni G; Zardi L Int J Cancer; 1994 Oct; 59(1):11-6. PubMed ID: 7927891 [TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody enhances ligand binding of fibronectin MSCRAMM (adhesin) from Streptococcus dysgalactiae. Speziale P; Joh D; Visai L; Bozzini S; House-Pompeo K; Lindberg M; Höök M J Biol Chem; 1996 Jan; 271(3):1371-8. PubMed ID: 8576126 [TBL] [Abstract][Full Text] [Related]
16. Epitope mapping by cDNA expression of a monoclonal antibody which inhibits the binding of von Willebrand factor to platelet glycoprotein IIb/IIIa. Piétu G; Ribba AS; Chérel G; Meyer D Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):711-5. PubMed ID: 1377911 [TBL] [Abstract][Full Text] [Related]
18. Expression of the alternatively spliced EIIIB segment of fibronectin. Peters JH; Trevithick JE; Johnson P; Hynes RO Cell Adhes Commun; 1995 Feb; 3(1):67-89. PubMed ID: 7538416 [TBL] [Abstract][Full Text] [Related]
19. Anticalins Reveal High Plasticity in the Mode of Complex Formation with a Common Tumor Antigen. Schiefner A; Gebauer M; Richter A; Skerra A Structure; 2018 Apr; 26(4):649-656.e3. PubMed ID: 29526433 [TBL] [Abstract][Full Text] [Related]
20. Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha4beta1 and alpha4beta7 integrins. Moyano JV; Carnemolla B; Domínguez-Jiménez C; García-Gila M; Albar JP; Sánchez-Aparicio P; Leprini A; Querzé G; Zardi L; Garcia-Pardo A J Biol Chem; 1997 Oct; 272(40):24832-6. PubMed ID: 9312081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]